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Abstract Apoptosis plays an essential role in the control
of erythropoiesis under normal and pathological condi-
tions. However, the contribution of individual proteins
within cell death signalling pathways remains poorly
defined. Here, we investigated the role of the pro-apoptotic
Bcl-2 family member Noxa in the regulation of erythro-
poiesis. We found that expression of Noxa is induced
during erythroid differentiation of human and murine pre-
cursor cells. Using in vitro model systems for erythroid
progenitors, we observed rapid induction of Noxa upon
cytokine deprivation. Knockdown or deletion of Noxa
conferred significant protection against apoptosis upon
cytokine withdrawal. In vivo, Noxa deficiency did not
affect hematological blood parameters or erythroid pro-
genitor composition of bone marrow and spleen under
steady-state conditions. In contrast, in a model of acute
haemolytic anemia, Noxa-deficiency enhanced hematocrit
recovery. Moreover, in a model of chronic inflammation-
induced anemia, Noxa-ablation resulted in a dramatic
increase of erythroblast expansion. Our data indicate that
induction of Noxa in erythroid progenitors sets a survival
threshold that limits expansion beyond the number of cells
that can be sustained by the available cytokines, which
becomes apparent under conditions of induced anemia.
Keywords Noxa  Erythropoiesis  Apoptosis 
Erythropoietin  Mcl-1
Introduction
Red blood cell (RBC) production is a strictly regulated
process and homeostatic maintenance of the erythropoietic
system requires a delicate balance between generation and
destruction of erythrocytes [1]. Hematopoietic cytokines
play a crucial role in regulating this homeostatic balance
and lack of appropriate growth factor stimulation results in
rapid progenitor cell death [2]. Erythropoietin (EPO) is a
lineage-specific hematopoietic cytokine [3] which func-
tions primarily as an erythroblast survival factor. Its anti-
apoptotic actions have been proposed to involve the
apoptotic regulators Bcl-XL and Bim [4], which are
prominent members of the Bcl-2 mitochondrial pathway of
apoptosis [5]. Bcl-XL belongs to the anti-apoptotic mem-
bers of the Bcl-2 family, which bind and antagonise pro-
apoptotic BH3-only proteins, such as Bim and Noxa.
Gene-targeting studies in mice have identified the
mitochondrial pathway of apoptosis as an important
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regulatory mechanism during erythropoiesis [6]. Mice that
lack Bcl-XL die in utero due to a failure of embryonic stem
cells to generate viable mature erythocytes [7]. Reduced
Bcl-XL expression in early erythroblasts results in inef-
fective erythropoiesis and anemia [7, 8]. Studies of Bim-
deficient mice showed that prevention of Bim activation is
a key component of survival signalling mediated by cyto-
kines in hematopoietic progenitors. EPO protects erythro-
blasts from apoptosis by downregulation of Bim expression
and enhanced ERK-mediated degradation of the Bim pro-
tein [9].
Unlike Bim, which potently engages all pro-survival
Bcl-2 molecules [10], Noxa exerts its pro-apoptotic func-
tion mainly by neutralizing the pro-survival Bcl-2 protein
Mcl-1 [11]. Previously, Mcl-1 has been shown to play a
detrimental role in the survival of hematopoietic progeni-
tors. Genetically modified mice in which Mcl-1 can be
deleted in an inducible fashion in hematopoietic stem cells
rapidly lost these cells after gene-deletion [12]. Unfortu-
nately, the strong phenotype of Mcl-1 deficiency prevents
detailed investigation of its role in cell specific functions.
In contrast, Noxa is thought to ‘sensitize’ cells to apoptotic
stimuli, rather than inducing cell death in itself [13]. Noxa
deficiency therefore allows investigation of the role of cell
death pathways in physiological processes via subtle
alteration of cell death sensitivity [14], rather than com-
plete abrogation of these pathways such as is the case for
Bim or Mcl-1 deficiency.
Previously, we have identified Noxa as an important
regulator of effector T and B cell expansion [14–16]. In
response to antigen, T and B cells rapidly induce Noxa,
which sets a survival threshold that depends on antigen-
affinity. This survival threshold ensures that, when lym-
phocytes of various affinities expand and compete for
nutrients and pro-survival cytokines, only high-affinity
cells prevail and are allowed to contribute to the effector
cell pool. Whether Noxa also mediates expansion capacity
of other cells within the hematopoietic lineage such as
erythroblasts is currently unknown. Interestingly, the pro-
survival activities of EPO have been proposed to involve
PI3-kinase, which is an important regulator of Mcl-1 pro-
tein levels [17]. Therefore, the Noxa/Mcl-1 axis may also
represent an important regulatory mechanism of erythro-
blast expansion under conditions of limiting EPO-
concentrations.
Hence, we here set out to investigate the role of Noxa in
regulating basal erythropoiesis and its contribution to
stress-erythropoiesis in vivo. We find that Noxa is induced
both in human and murine eryhtroid precursors. In vitro,
reduced Noxa levels conferred a significant survival
advantage of erythroid precursors upon cytokine-depriva-
tion. In vivo, Noxa-deficiency did not affect the erythroid
compartment under homeostatic conditions, but resulted in
greatly enhanced erythroblast expansion in a model of
chronic inflammation-induced anemia. In a model for acute
haemolytic anemia, Noxa-deficiency enhanced hematocrit
recovery. Our findings provide new insights in the regu-
lation of erythropoiesis during acute and chronic anemia




C57BL/6 (B6) JAX mice were purchased from Charles
River and kept as breeding colonies in our local animal
facility. Only these mice, which were kept under identical
conditions as our knock-out mice, were used as WT con-
trols in our experiments, unless stated otherwise. Noxa-/-
mice were a kind gift from Dr. A. Strasser (WEHI, Mel-
bourne) and provided by Dr. M. Serrano (CNIO, Madrid).
Bim-/- mice, WT and Noxa-/- controls for colony for-
mation experiments were bred and housed in the central
animal facility of the Innsbruck Medical University.
CD70TG mice were generated as described previously [18].
Mice were used at 6–12 weeks of age, unless stated
otherwise, age- and sex-matched within experiments and
were handled in accordance with institutional and national
guidelines. All mice were either generated in B6 mice or
backcrossed at least ten times on this background.
Culture
Mononuclear cells were isolated from peripheral blood by
density centrifugation over a Ficoll-Paque solution (density
1.077 g/mL). Immunomagnetic cell separation (Miltenyi
Biotec) was used to isolate CD34? cells. Erythrocytes
were generated using a modified two-phase culturing sys-
tem as described by Giarratana et al. [19]. Briefly, CD34?
cells were cultured in IMDM supplemented with 1 %
bovine serum albumin (BSA), 120 g/mL iron-saturated
human transferrin, 900 ng/mL ferrous sulfate, 90 ng/mL
ferric nitrate, and 10 g/mL insulin (Sigma-Aldrich GmbH).
Erythrocyte differentiation was induced on the addition of
100 ng/mL stem cell factor (SCF) (R&D systems), 10-6 M
hydrocortisone (Sigma-Aldrich GmbH), 5 ng/mL interleu-
kin-3 (IL-3) (R&D systems), and 3 IU/mL EPO (Ar-
anesp). After 8 days of culture, erythroblasts were
cultured in the presence of EPO until day 14.
TF-1, FDM-WT and FDM-Noxa-/- cells were gener-
ated as described previously [20] and maintained in RPMI
(Invitrogen supplemented with 10 % fetal bovine serum
(PAA Laboratories GmbH), 100 lg/mL Gentamycin
(Invitrogen), 2 mM L-Glutamine (2 mM), 0,5 mM
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b-mercapto-ethanol (Sigma-Aldrich GmbH), and 0.1 ng/mL
human recombinant IL-3 (R&D systems) at 37 C and 5 %
CO2.
Lentiviral-mediated shRNA targeting
Lentiviral shRNA clones (Sigma Mission RNAi) targeting
Noxa and a scrambled non-targeting control (SHC002)
were purchased from Sigma. These vectors were co-
transfected with the packaging vectors psMD2G, pMDLg/
pRRE and pRSV-Rev into 293T cells using Fugene6
(Roche Applied Science) to produce the virus. After 48 h,
lentiviral vector particles were harvested, virus superna-
tants were filtered with 0.22-lm filters and stored at
-80 C. Efficiency of different lentiviral shRNA clones in
cells was determined by Western blot. TF-1 cells were
transduced by a single round infection for 24 h using a
combination of 5 different Sigma Mission RNAi clones,
followed by puromycin (Sigma-Aldrich GmbH) selection
(1 lg/mL) for 1 week.
Measurement of apoptosis
Apoptotic cells were measured by staining with Annexin
V-FITC (IQ Products, Groningen, The Netherlands)
according to the manufacturer’s protocol for 20 min.
Before analysis of the samples by FACS, propidium iodide
(PI) (Sigma-Aldrich GmbH) was added (5 lg/mL). Viable
cells were defined by Annexin V-/PI- staining. Alterna-
tively, cells were incubated with 200 nM Mitotracker
(Molecular Probes) [21] for 30 min at 37 C, washed, and
double stained with Annexin V-APC. Viable cells were
defined as Mitotracker hi/Annexin V-.
Western blot analysis
Western blot analysis was performed using standard tech-
niques. In brief, cells were lysed in Laemmli buffer
(0.12 M Tris–HCl pH 6.8, 4 % SDS, 20 % glycerol,
0.05 lg/lL bromophenol blue, and 50 mM Dithiothreitol)
and boiled for 5 min. Protein contents were determined by
the Bio-Rad protein assay (Bio-Rad Laboratories, Mun-
chen, Germany) and equal amounts of total lysate were
analyzed by 12 % SDS–polyacrylamide gel electrophore-
sis. Proteins were transferred to Immobilon-P and incu-
bated with Tris buffered saline (TBS) containing 2 % low-
fat milk for 1 h before incubating with an antibody against
Noxa (Imgenex, San Diego, CA), Bcl-XL (Transduction
Laboratories, Lexington, KY), Bim (Stressgen Bioreagents
Canada), Puma (Cell Signaling), Bcl-2 (Alexis Biochemi-
cals) or b-actin (Santa Cruz Biotechnology, Santa Cruz,
CA) overnight at 4 C in TBS-Tween. Blots were subse-
quently incubated with IRDye 680 or 800 labelled
secondary antibodies for 1 h. Odyssey Imager (Li-Cor) was
used as a detection method according to the manufacturer’s
protocol.
Flow cytometry and histology
Murine single-cell suspensions were obtained by mincing
the specified organs through 40 lm cell strainers (Becton–
Dickinson). Whole blood and tissue homogenate cell
counts were measured on heparinized blood using an
automated cell counter (Beckman Coulter). Cells (5 9 105
to 5 9 106) were collected in staining buffer (PBS with
0.5 % BSA) and stained for 30 min at 4 C with antibodies
against Ter119 (Ter119), CD71 (R17217) and CD117
(2B8). For FACS analysis of reticulocytes, 3–5 lL of
heparinized blood was washed in staining buffer and
stained for CD71. Cells were washed and resuspended in
staining buffer, after which Thiazole Orange (Sigma-
Aldrich GmbH) was added to a final concentration of 1 ng/mL
and immediately analyzed. FACS experiments were per-
formed on a FACSCalibur or FACSCanto (Becton–Dick-
inson) and analysed with FlowJo software (TriStar). All
FACS antibodies were obtained from eBioscience. Stan-
dard haematoxylin and eosin staining was performed on
PFA fixed, paraffin embedded tissues. Pictures were taken
using a Leica microscope.
RT-MLPA (Reverse transcriptase multiplex ligation-
dependent amplification)
Total RNA for Reverse Transcriptase Multiplex Ligation-
dependent Probe Amplification (RT-MLPA) was extracted
using the Trizol isolation method (Invitrogen). mRNA
levels were analyzed with the SALSA RT-MLPA Apop-
tosis kit R011-C1 (MRC-Holland, http://www.mlpa.com)
according to the manufacturer’s instructions. Samples were
run through a Genescan and analyzed with GeneMapper
(Applied Biosystems GmbH; http://www.appliedbiosys
tems.com) and subsequently with Excel software (Micro-
soft), as described previously [22, 23].
EPO ELISA and anemia induction
Serum EPO levels of mice were quantified by using the
Quantikine Mouse/Rat EPO Immunoassay (R&D Systems)
as described by the manufacturer. Acute anemia was
induced by a single i.p. injection of 60 mg/kg phen-
ylhydrazine (Sigma-Aldrich GmbH).
Methylcellulose cultures
To determine colony forming unit-erythroid (CFU-e) and
burst forming unit erythroid (BFU-e) potential, 3.75 9 105
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total bone marrow or 7.5 9 105 total spleen cells were
resuspended into 325 lL Iscove’s Modified Dulbecco’s
Medium (IMDM). Cells were subsequently resuspended in
3.2 mL methylcellulose medium (MethoCult M3234,
StemCell Technologies) supplemented with 4U mL human
recombinant EPO (Aranesp), 100 ng/mL murine recom-
binant SCF, 20 lg/mL iron-saturated human transferrin,
2 9 10-4 M hemin (Sigma-Aldrich), 1 % gentamycin and
plated in triplo. CFU-e colonies were counted on day 3,
BFU-e colonies on day 8 after plating.
Statistical analysis
Statistical analysis was performed using the unpaired Stu-
dent’s t test, Wilcoxon rank-sum test or one-way ANOVA
test where applicable. Asterisks denote significant differ-
ences (*p \ 0.05, **p \ 0.005, ***p \ 0.0005).
Results
Induction of Noxa in human hematopoietic progenitors
during erythroid development
To explore the contribution of cell death regulators in the
erythroid system, we analyzed the expression levels of Bcl-
2 family members at different stages of erythroid devel-
opment utilizing an ex vivo differentiation system. For this
purpose, human CD34? hematopoietic progenitors, iso-
lated from peripheral blood, were cultured in presence of
EPO, IL-3, SCF and hydrocortisone to induce erythrocyte
differentiation. After 8 and 12 days, the majority of cells
was characterized as erythroblast on the basis of mor-
phology (data not shown), loss of CD34 expression and
increased expression of erythrocyte markers CD71 and
CD235a (Fig. 1a). At different time points, total mRNA
was extracted from cells undergoing differentiation and
expression levels of pro- and anti-apoptotic molecules was
analyzed by RT-MLPA [23] (Fig. 1b). Of the BH3-only
molecules, Noxa expression was downregulated during
early stages of erythroid differentiation but increased as the
majority of cells reached the erythroblast stage after day 8.
Bim levels, on the other hand, steadily increased over time
and reached a maximum on day 8. Analysis of pro-survival
Bcl-2 family members revealed that human CD34?
hematopoietic cells express Bcl-2 at relatively high levels,
which decline as cells undergo erythroid differentiation.
Conversely, Bcl-XL is induced during differentiation
towards the erythroid lineage. mRNA levels of Mcl-1 and
Bfl-1/A1 remained relatively unchanged during differenti-
ation (Fig. 1b, right panel and data not shown).
Since Noxa and its pro-survival antagonist Mcl-1 are
highly regulated on a post-transcriptional level [17],
Western blot analysis was performed to investigate whe-
ther the mRNA levels of these genes corresponded with
protein expression (Fig. 1c). Noxa protein correlated clo-
sely with the fluctuations in its mRNA transcripts. Notably,
changes in Noxa mRNA expression preceded changes on a
protein level. Mcl-1 protein corresponded less well with its
mRNA levels. Mcl-1 protein followed a similar expression
level as Noxa, suggesting a role for these binding partners
in the regulation of erythropoiesis.
Noxa regulates survival of erythroid progenitors
under cytokine limiting conditions
To study the correlation between Noxa expression and cell
viability of erythroid cells, TF-1 cells were used as a
defined cell line model for the regulation of erythropoiesis.
TF-1 cells are committed early erythroid CD34? cells,
which are maintained in undifferentiated state in the
presence of IL-3 or GM-CSF [24]. When cultured with
EPO, these cells differentiate and obtain a phenotype that
resembles that of erythroid precursors.
TF-1 cells were cultured in presence of EPO and their
erythroid phenotype was characterized. Upon differentia-
tion towards the RBC lineage, CD34 was downregulated
and expression of the transferrin receptor (CD71) was
induced (Fig. 2a). At protein level, Mcl-1 and Bcl-XL were
highly expressed in this transformed cell line, and dis-
played no changes after EPO treatment (Fig. 2b). Bim was
rapidly induced in presence of EPO, whereas Noxa
expression was upregulated from day three onwards. These
findings correspond well with our observations in primary
human cells (Fig. 1).
To study responses to cytokine deprivation, TF-1 cells
were cultured for 4 days with either IL-3 or EPO and
subsequently deprived of cytokine for 24, 48 and 72 h.
Viability was assessed by staining for Annexin V/PI. Fol-
lowing withdrawal of IL-3 or deprivation of EPO, TF-1
cells underwent rapid apoptosis, which corresponded with
induction of Noxa protein (Fig. 2c, d). To investigate
whether Noxa contributed to cytokine deprivation-induced
cell death in TF-1 cells, a short hairpin RNA (shRNA)
approach was used to reduce Noxa levels in TF-1 cells
(Fig. 2e). Indeed, knockdown of Noxa conferred sub-
stantial protection from apoptosis induced by either IL-3 or
EPO deprivation (Fig. 2f).
Finally, we investigated whether Noxa mediates its pro-
survival effect via regulation of Mcl-1 protein levels. Upon
binding, Noxa can target Mcl-1 for proteasomal degrada-
tion [11]. Therefore, we monitored Mcl-1 protein levels in
EPO-differentiated TF-1 cells, and observed that Mcl-1
levels rapidly declined upon EPO-deprivation (Fig. 2g).
Moreover, cells in which Noxa was knocked down had
significantly higher levels of Mcl-1 under homeostatic
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conditions, which remained higher after deprivation of
EPO.
Together, these data show that Noxa is involved in
regulating apoptosis of hematopoietic progenitor cells
under cytokine limiting conditions via control of Mcl-1
protein levels.
Noxa regulates survival of murine erythroid progenitors
under cytokine limiting conditions
In order to investigate the contribution of Noxa to eryth-
ropoiesis in vivo, we first determined whether Noxa regu-
lation is similar in mice and human erythropoiesis.
Megakaryocyte/erythrocyte precursors (MEP) and more
differentiated CD71? erythroblasts were purified and
mRNA levels of Bcl-2 family members was compared with
that of early hematopoietic precursors. Similar to human
erythropoiesis, Bcl-2 was downregulated, whereas Bcl-XL
was strongly induced in erythroblasts (Fig. 3a). In addition,
Bim and Noxa transcript levels increased during erythroid
differentiation, whereas Mcl-1 levels slightly decreased.
Thus, Noxa mRNA appears to follow a similar expression
pattern in murine and human erythroid development. Due
to lack of reliable antibodies for murine Noxa, we were
unable to monitor protein levels.
These findings prompted us to investigate whether Noxa
also mediates cell death upon cytokine deprivation of
murine hematopoietic precursors. Since there are no

























































































Fig. 1 Noxa is induced in human hematopoietic progenitors during
early erythroid development. a Purified CD34? progenitors from
peripheral blood were differentiated towards erythroblasts in 14 days.
FACS analysis of cell cultures shows erythroid differentiation as
exemplified by acquisition of CD71 and CD235a and loss of the stem
cell marker CD34 in one representative experiment of 4 performed.
b Expression profiling by RT-MLPA, reveals induction of Noxa, Bim
and Bcl-XL and downregulation of Bcl-2 during erythroid develop-
ment. Average of 4 independent experiments is shown, expressed as
log transformed expression data in relation to day 2 of culture. The
number of cells and the yield of RNA at day 0 was too low to allow
reproducible analysis. c Protein lysates were prepared from CD34?
cells undergoing erythroid differentiation for 2, 8 and 12 days.
Western blot analysis was performed using antibodies against Noxa,
Bim, Puma, Bcl-XL, Mcl-1 and Bcl-2. b-Actin is used as loading
control. Similar results were obtained in two independent experi-
ments. To compensate for low cell numbers, protein lysates on day 2
were pooled. Asterisks mark non-specific bands. Error bars represent
SEM
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murine pre-erythroid cell lines available with similar
characteristics as TF-1 cells, we used IL-3 dependent cells
(factor-dependent myeloid—FDM) generated from WT
mice or animals lacking Noxa (Noxa-/-) [20]. WT- and
Noxa-/--FDM cells were deprived of IL-3 for 48 h and
viability was assessed. Loss of Noxa in FDM cells resulted
in increased resistance to apoptosis following IL-3 depri-
vation compared to WT-FDM cells (Fig. 3b). Similar to
EPO-deprived TF-1 cells, Mcl-1 protein levels rapidly
declined in FDM cells when IL-3 was removed, in a con-
centration-dependent fashion. In Noxa-/--FDM cells,
decrease of Mcl-1 protein was notably less upon IL-3
deprivation, compared to WT-FDM cells (Fig. 3c).
These findings indicate that also in mouse hematopoietic
precursors, Noxa mediates survival via regulation of Mcl-1
protein levels upon cytokine deprivation.
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Fig. 2 Noxa regulates survival of erythroid progenitors under
cytokine limiting conditions. a TF-1 cells were cultured either in
presence of IL-3 or EPO. Expression of CD34 and CD71 was
analyzed by flow cytometry. The percentage of CD34-CD71? cells is
depicted. b TF-1 cells were cultured in the presence of EPO. At the
indicated days, protein lysates were analysed using antibodies against
Noxa, Bcl-XL, Mcl-1 and Bim-XL. Shown are samples of a single
experiment, loaded on two separate gels, each with their own b-actin
loading control. c TF-1 cells were cultured either in presence of IL-3
or EPO. After 4 days, cells were deprived of EPO or IL-3 and
viability was determined by Annexin V/PI staining. One of 4
experiments is shown. d TF-1 cells were cultured either in presence of
IL-3 (left) or EPO (right). After 4 days of culture, cells were deprived
of EPO or IL-3 for indicated times and Noxa protein levels were
determined by western blot. b-Actin was used as loading control.
e Western blot showing expression of Noxa and Actin after
knockdown of Noxa in TF-1 cells using a lentiviral vector containing
a shRNA targeting Noxa (Noxa-i) or a scrambled non-targeting
control (Ctrl-i). Noxa expression was induced upon culture in
presence of 5 lM Bortezomib for 4 h prior to lysis. f Noxa-i or
Ctrl-i cells were cultured with IL-3 or EPO for 4 days and
subsequently deprived of either IL-3 or EPO for 72 h. Shown is
viability, measured by Annexin V/PI staining, from the start of
cytokine deprivation. Averages are shown of 9 independent exper-
iments. g Noxa-i and Ctrl-i cells were cultured in presence of EPO for
4 days and subsequently deprived of this cytokine. After the indicated
days, Mcl-1 protein levels were determined. b-Actin was used as a
loading control. One of three experiments is shown. Error bars
represent SEM
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Noxa deficiency under homeostatic conditions results
in mild anisocytosis in vivo
Having established the effects of Noxa on cell viability of
erythroid cells in vitro, we next determined the physio-
logical impact of Noxa-ablation on erythroid development
in vivo. Erythroblast subsets [8] were quantified in spleen
and bone marrow (BM) of WT and Noxa-/- mice [25], but
no differences were observed in either erythropoietic organ
(Fig. 4a, b). To assess the clonogenic capacity of WT and
Noxa-/- spleen- and BM-resident erythroid progenitors,
the number of CFU-e and BFU-e colonies was determined
after 3 and 8 days of culture respectively (Fig. 4c, d). Noxa
deletion did not significantly affect the colony forming
capacity of either bone marrow- or spleen-derived pro-
genitors. Furthermore, hematological blood parameters,
including RBC numbers, hemoglobin levels, and hemato-
crit appeared normal when compared to syngeneic control
mice (Table 1). Also when old mice of 21 months were
investigated, we did not observe major alterations in their
blood parameters (Table 1). In young mice, we only
observed a mild increase in red cell distribution width
(RDW), also called anisocytosis, which might indicate
alterations in RBC production or turnover (Table 1). To
determine RBC turnover rates, we compared the half-life of
RBCs by measuring loss of biotinylated cells following
in vivo labeling. No differences were observed between
control and Noxa deficient mice, excluding the possibility
that survival of mature erythrocytes is affected in the
absence of Noxa (Fig. 4e). In addition, no alterations in
EPO levels were observed (Fig. 4f), excluding an effect of
Noxa ablation on endocrine cells.
Thus, even though Noxa mediates apoptosis of murine
hematopoietic precursors under conditions of cytokine
deprivation in vitro, its ablation has no discernible effects
on the RBC compartment under homeostatic conditions.
Noxa ablation results in enhanced acute stress-
erythropoiesis
Considering the Noxa induction in erythroid progenitors
and its regulatory role upon cytokine deprivation, the
absence of an effect of Noxa-ablation on erythropoiesis
appears unexpected. However, in homeostasis growth
factors are amply available. The role of Noxa in erythro-
poiesis may thus only become apparent under conditions
when expanding erythroid precursors are limited in their
access to pro-survival cytokines. Indeed, when hemato-
poietic precursor cells were isolated from bone marrow and
deprived from survival factors for 32 h before placing them
in colony forming assays, Noxa-ablation provided a sig-
nificant survival advantage to CFU-e progenitors compared
to WT controls. In comparison, this survival advantage was
increased considerably in cells deficient for Bim (Fig. 5a).
These findings suggested a role for Noxa when rapidly
expanding erythroblasts must compete for the available
growth factors, such as during acute anemia. Injection of
phenylhydrazine (PHZ) in mice results in rapid haemolytic
anemia, which is followed by robust proliferation of RBC
precursors to compensate for RBC loss. Even though PHZ
treatment results in an increase of serum EPO levels, this
hormone is still rate-limiting for RBC expansion, as appli-
cation of exogenous EPO results in increased RBC counts











































































Fig. 3 Noxa regulates survival of murine erythroid progenitor cells
under cytokine limiting conditions. a Relative gene expression of
sorted bone marrow derived murine MEPs (Lin-CD117?
CD34-CD16-) and splenic CD71? cells, compared to the expression
in HSC/CMPs (Lin-CD117?CD34?CD16Dim), measured by RT-
MLPA. Data is expressed on a logarithmic scale. Error bars represent
SEM (n = 3). b FDM cells generated from WT or Noxa-/- mice
were deprived of IL-3 for 2 days. Viability was determined by
staining for sub-G1 DNA containing cells. Data represent the mean of
5 experiments. Error bars represent SEM. c Western blot analysis of
Mcl-1 levels in WT- or Noxa-/--FDM cells cultured for 2 days in the
presence of the minimal IL-3 concentration that sustained full
proliferation and survival (?IL-3), 10 % of that concentration
(0.1 9 IL-3) or in absence of IL-3 (-IL-3). b-Actin is used as a
control for equal loading
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injected with PHZ [8, 27] to investigate recovery from acute
anemia. After 3 days, hematocrit, RBC counts and reticu-
locyte counts were measured (Fig. 5b). RBC counts and
hematocrit of WT mice were reduced to almost half the
starting value. Hematocrit and RBC counts of Noxa-/- mice
were also considerably reduced, but showed significantly
higher values than those of WT controls (Fig. 5b, c). Fur-
thermore, reticulocyte numbers of Noxa-deficient mice were
significantly higher following PHZ treatment compared to
control mice (Fig. 5d). This indicates that Noxa deficiency
results in enhanced RBC production, rather than protection
against hemolysis.
Together, these data show that Noxa limits expansion of
erythroid precursor cells under conditions of acute stress.
Noxa ablation results in enhanced inflammation-
induced stress-erythropoiesis
To corroborate our findings in a second system of stress-
induced erythropoiesis, we made use of an available
genetic model. CD70-transgenic (CD70TG) mice over-
express the T cell co-stimulatory molecule CD70 on B cells
and as a result have a high number of effector T cells in the
bone marrow. Previously, we showed that IFNc-production









































































































Fig. 4 Noxa-deficiency does
not affect erythropoiesis under
homeostatic conditions.
a–b Absolute numbers of
erythroblast subsets in a spleen
and b bone marrow of WT and
Noxa-/- mice. c–d Number of
CFU-e and BFU-e colonies after




factors, using c 1 9 105 Bone
marrow or d 2 9 105 spleen
cells of WT and Noxa-/- mice.
Data show mean values ±SEM
of at least 4 independent
experiments with 3 mice in each
experiment. e WT and Noxa-/-
mice were injected with active
biotin. Percentage of
biotinylated red blood cells was
followed over time by FACS.
Data show mean values ± SEM
of an experiment using 3 mice
per group. f EPO levels (ng/mL)
in the serum of WT and
Noxa-/- mice, as determined by
ELISA
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by these cells induces PU.1 in hematopoietic progenitors,
which chronically impairs erythropoiesis in the bone mar-
row and causes severe anemia over time [28]. Since the
spleen is the primary site of anemia-induced erythropoiesis
in mice, CD70TG mice have increased splenic stress-
erythropoiesis [28]. We crossed Noxa-deficient animals
with CD70TG mice to generate Noxa70 mice [29], and
investigated the effect of Noxa ablation on erythropoiesis
in this system. When the blood of 12 week old mice was
investigated, we observed clear symptoms of anemia in
Noxa70 mice, as the RBC count and hemoglobin levels
were significantly reduced compared to WT and Noxa-/-
controls (Fig. 6a; Table 2). However, no significant
decrease was observed compared to CD70TG mice. Strik-
ingly, reticulocyte numbers were greatly increased in
Noxa70 mice, indicating that these animals have increased
RBC production. Indeed, whereas the number of white
blood cells in the spleens of Noxa70 mice remained rela-
tively constant (Fig. 6b, c), the splenic weight of these
animals increased dramatically over time, suggesting
increasingly extensive extramedullary erythropoiesis. This
was confirmed by histological analysis of spleens, which
revealed a greatly enlarged red pulpa in Noxa70 mice
(Fig. 6d). Detailed analysis of cell subsets revealed that
Noxa-deficiency in CD70TG mice resulted in a dramatic
increase of erythroblast precursor populations. This
increase was observed both for early and late erythroid
progenitors (Fig. 6e, f). Thus, also in a genetic model for
chronic inflammation-induced stress, Noxa-deficiency
results in an enhanced expansion of erythroid progenitors.
In summary, Noxa controls expansion of erythroid
precursors and RBC production in vivo under conditions of
induced anemia.
Discussion
Shortage of growth factors or nutrients triggers the mito-
chondrial apoptosis pathway resulting in rapid initiation of
cell death, which is critically dependent on Bcl-2 family
Table 1 Characteristics of the RBC compartment in Noxa-deficient mice compared to syngeneic control mice
8 weeks 21 months
WT Noxa-/- WT Noxa-/-
Reticulocytes (%) 1.69 (0.32) 1.83 (0.64) 4.11 (0.30) 5.63 (0.78)
RBCs 9 1012 L 9.09 (0.69) 8.61 (0.75) 8.13 (0.32) 8.00 (0.40)
Hemoglobin (mM) 9.73 (0.84) 9.00 (0.99) 4.10 (0.13) 4.08 (0.21)
Hematocrit (L/L) 53.90 (3.93) 53.77 (4.05) 54.95 (2.40) 50.34 (4.62)
RDW (%) 18.79 (1.19) 20.82 (3.05)a 19.3 (0.40) 19.35 (0.65)
MCV (fL) 58.31 (6.68) 60.12 (4.52) ND ND
MCH (fmol) 1.03 (0.04) 1.05 (0.03)a 1.00 (0.01) 1.03 (0.01)
MCHC (mM) 18.00 (2.39) 17.80 (1.59) ND ND
WBC 9 108 L 8.66 (2.62) 12.16 (6.07)a 9.66 (3.02) 12.2 (4.10)












































































Fig. 5 Noxa-deficiency provides partial protection against phen-
ylhydrazine-induced acute haemolytic anemia. a 1 9 105 Bone
marrow cells of WT, Noxa-/- or Bim-/- were plated in semi-solid
media following 32 h of culture in the absence of cytokines. After
3 days, CFU-e colonies were counted. The data show the number of
colonies in cytokine deprived cultures. Data show a representative
experiment of 4 independent experiments with 3 mice in each
experiment. b–d WT and Noxa-/- mice were injected i.p. with
60 mg/kg PHZ. 3 days after administration. b Red blood cell count,
c hematocrit, and d reticulocyte count were determined. One of two
independent experiments is shown, using 3–7 mice per experiment.
Error bars represent SEM. *p \ 0.05 (Student’s t test)
































































































































































Fig. 6 Increased expansion of erythroid progenitors in a model for
inflammation-induced stress-erythropoiesis. Noxa-/- mice were
crossed with CD70TG mice, to generate Noxa70 mice and were
compared with WT, Noxa-/- and CD70TG animals. a Hematological
blood parameters of 12 week old mice. b Splenic weight and
c number of white blood cells in the spleens of mice at 8, 12 and
16 weeks of age. d HE staining of spleens of mice at 8 weeks of age
(259 enlarged). e Absolute number of the erythroid progenitor
populations Pro-E (CD71?Ter119Dim), Ery-A (CD71?Ter119?
FSCHigh) and Ery-B (CD71?Ter119?FSCLow) in 8 week old mice.
f Representative FACS plots of data shown in e. Gated is for
nucleated cells (i.e. Ery-C and mature red blood cells are excluded).
Right most plot shows which gates contain Erythroblast subsets. 3–4
animals are used per experiment. Error bars represent SEM.
* p \ 0.05, ** p \ 0.005, *** p \ 0.0005 (Student’s t test)
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members. BH3-only proteins Bim and Puma have been
demonstrated to play an important role in regulating the
survival of hematopoietic cells [9, 20, 30–33]. Here we
show that BH3-only protein Noxa regulates cell death of
erythroid progenitors upon cytokine deprivation in vitro.
In vivo Noxa regulates RBC production under conditions
of anemic stress, when proper control of RBC expansion is
required.
Noxa-/- mice did not show elevated hematological
blood parameters or increased erythroblast numbers in
spleen and bone marrow under steady-state conditions,
despite its induction during erythroid differentiation. In
models of induced anemia, on the other hand, Noxa-defi-
ciency promoted erythroblast expansion and enhanced
recovery of hematocrit levels. Also when hematopoietic
precursors were deprived of cytokines in vitro, Noxa
mediated cell death of these cells. These findings indicate
that apoptotic regulation of RBC production mediated by
Noxa depends on the cellular demand of available vital
cytokines. When expanding erythroblasts compete for
limiting amounts of resources, which is particularly strong
during stress-erythropoiesis, the non-redundant role of this
pro-apoptotic protein became apparent. These observations
are strikingly similar to our findings in lymphocytes.
Noxa-/- mice have no alterations in their T or B cell
compartment under homeostatic conditions, when the
amount of available pro-survival cytokines is abundant. In
contrast, when these cells are activated, Noxa is induced
and cells have to compete for the limiting amount of
available nutrients. In WT mice, low-affinity cells have a
competitive disadvantage and undergo Noxa-mediated
apoptosis. In Noxa-deficient mice, these cells are allowed
to survive and impact the affinity of T and B cell responses
[14–16, 34]. Taken together, these findings indicate that
Noxa-mediated apoptosis represents a general regulatory
mechanism of highly expanding hematopoietic cells, that
prevents expansion beyond the number of cells that can be
sustained by the available cytokines.
The large number of EPO-regulated survival pathways
that have been identified over the years [1, 35] may rep-
resent redundancy, but may also indicate separate functions
at different biological stages. Noxa-deficiency rescued
cytokine-deprived RBC precursors, but less so than Bim-
deficiency (Fig. 5a). This difference in effect corresponds
with the death-inducing potential of BH3-only proteins.
Bim is considered a strong-inducer of apoptosis, since it
interacts with all Bcl-2 family members and is able to
induce cell death on its own [36, 37]. Noxa, on the other
hand only interacts with Mcl-1 and A1 and its over-
expression only increases sensitivity to pro-apoptotic
stimuli [36, 37]. It appears that the death-inducing potential
of these molecules is used to accomplish different levels of
control over RBC expansion. Even though erythroid line-
age commitment results in induction of both Bim and
Noxa, only the former is required to regulate erythroblast
expansion under homeostatic conditions [38]. However,
under conditions of stress, when various activating stimuli
induce rigorous proliferation in RBC precursors, Noxa aids
Bim in preventing cellular increase beyond the number that
can be sustained by the available amount of pro-survival
factors. Thus, Noxa-mediated control of erythroblast
expansion represents an additional layer of regulation for
RBC expansion which only operates during stress-eryth-
ropoiesis, when Bim-mediated control is insufficient.
In summary, Noxa and its antagonist Mcl-1 are part of
an important component of the mechanisms to re-establish
RBC numbers upon blood loss and modulation of this
pathway could be envisaged in therapeutic options for
treatment of anemia.
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